Friday, December 07, 2007 2:21:23 PM
Pay close attention to any SEC filings in the next 6 months, I'm certain they will adjust their stock based compensation to make up for any loses the RS has done. May find it in the 10Q. A side note on the frequent changes in accounting firms, usually means that the old accounting firm refused to fudge the numbers on Cytocore's behalf, think about that!
Most brokers will provide detailed quotes on insider action but you can also find it here:
http://www.cnbc.com/id/15837285?q=cyoe
Funny thing is that one only gets to see who is dumping after the fact since the paper trial of whom they are selling equity interest to is next to nothing. Intentional in my opinion because they don't want retail to know how much they are diluting the float and at what price they are selling.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM